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ABSTRACT 
 
 
 
Berntson, Jessica. M.S., Purdue University, December 2015. Depressive Symptom 
Severity, Stressful Life Events, and Subclinical Atherosclerosis in African American 
Adults. Major Professor: Jesse C. Stewart. 
 
 
 
Prospective epidemiologic evidence indicates that both stressful life events 
(SLEs) and depression are associated with an increased risk of subclinical atherosclerosis 
and cardiovascular disease (CVD) events. Even though stressful life events (SLEs) and 
depression co-occur and may act together to influence cardiovascular disease (CVD) risk, 
these psychosocial factors have been mainly examined in isolation. For instance, 
depression may moderate the relationship between SLEs and CVD outcomes. I 
hypothesized that depressive symptoms would potentiate the deleterious effect of SLEs 
on subclinical atherosclerosis. This hypothesis is plausible, given that depressed adults 
exhibit exaggerated and prolonged sympathetic nervous system, hypothalamic-pituitary-
adrenal (HPA) axis, and inflammatory responses to stress, which in turn could promote 
atherosclerosis. As compared to their nondepressed counterparts, depressed individuals 
may also be more likely to engage in maladaptive methods to cope with SLEs (e.g., 
increased tobacco use, alcohol use, and consumption of low-nutrient, energy dense 
foods), which could also promote atherosclerosis. I examined cross-sectional data from 
274 to 279 (depending on the outcome measure) older, African American adults (mean 
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age = 66 years, 67% female) with no evidence of clinical CVD or dementia who 
participated in the St. Louis African American Health-Heart study (2009–2011). Number 
of SLEs was assessed using the Life Events Calendar, a structured interview. From this 
interview, a continuous SLEs variable was computed (number of adult SLEs: 0, 1, 2, 3, 4, 
5, 6, 7, 8, 9, 10, or 11+). Severity of depression symptoms was measured using the 17-
item Hamilton Rating Scale for Depression (HAM-D). Two measures of subclinical 
atherosclerosis were obtained: carotid intima-media thickness (CIMT; assessed by 
ultrasonography) and coronary artery calcification (CAC; assessed by multi-detector 
computerized tomography). I conducted linear (CIMT) and logistic (CAC) regression 
models, first adjusted for demographics (age, sex, education) and then fully-adjusted 
(demographics; mean arterial pressure; low density lipoprotein cholesterol (LDL-C), high 
density lipoprotein cholesterol (HDL-C); hemoglobin A1c; BMI; tobacco use; diabetes 
diagnosis; and use of antihypertensitve, lipid lowering, antidiabetic, and antidepressant 
medications). No main effects of SLEs or HAM-D were found for CIMT or CAC. There 
were also no SLEs by HAM-D interactions for CIMT or CAC. Because the current 
results are largely inconsistent with prior literature and there is a paucity of studies 
utilizing African American samples, future research is needed to examine the 
independent and interactive associations of SLEs and depressive symptoms with 
measures of subclinical atherosclerosis. If the present results are replicated, it may 
suggest that SLEs, depressive symptoms, and their interactive effect are not cardiotoxic 
among African American adults.
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INTRODUCTION 
Cardiovascular Disease 
Epidemiology 
CVD refers to disorders of the heart and the vascular system, which include 
coronary artery disease, congestive heart failure, stroke, and hypertension. The 
prevalence of CVD is on the rise in the U.S., with estimates of more than 1 in 3 
Americans currently experiencing some form of CVD (Rosamond et al., 2007). Perhaps 
more concerning, CVD is the number one cause of mortality in adults, accounting for 
39% of all deaths (Clouse, 2006). Moreover, there are exorbitant costs for treating 
advanced CVD. The American Heart Association forecasts that, by 2030, the total cost of 
CVD will exceed $1 trillion (Heidenreich et al., 2011). Also by that time, it is expected 
41% of the U.S. population will have some form of CVD.  
Given the immense burden of CVD, it is important to consider those at greatest 
risk of the disease. African Americans are one group at increased risk for both CVD 
morbidity and mortality. Among African Americans adults, 44% of men and 49% of 
women have CVD (Go et al., 2013). Not only is CVD the leading cause of death in 
African Americans but more African Americans experience fatal CVD events than any 
other racial/ethnic groups in the U.S. (Yancy & Sica, 2004). Specifically, the death rate
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 from CVD in 2009 was 39% higher for African Americans than for Caucasians (Go et 
al., 2013). Furthermore, although deaths attributable to CVD have been declining in 
recent years, this decline has been less pronounced for African Americans than for 
Caucasians (Mensah, Mokdad, Ford, Greenlund, & Croft, 2005). 
Due to the increasing prevalence and costs of CVD, the need for prevention 
efforts is greater now than ever before. Fortunately, many CVD risk factors are 
modifiable. Moreover, among the preventive strategies recommended by the American 
Heart Association is the early detection and management of CVD risk factors 
(Heidenreich et al., 2011). To achieve this goal, it is imperative to enhance our 
understanding of conventional and emerging CVD risk factors and their interactions, 
especially in high-risk populations such as African Americans. 
Pathophysiology 
Although CVD includes a variety of conditions, the focus of this study is the type 
that arises from atherosclerosis. Therefore, from this point forward, CVD will refer to 
atherosclerotic CVD, a progressive systemic disease process involving the thickening and 
hardening of the blood vessels in the heart, brain, and peripheral circulation (Santos & 
Nasir, 2009). The arterial walls of these blood vessels are composed of three layers: 
adventitia, tunica media, and tunica intima (Libby, 2004). The outer layer (adventitia) 
contains collagen fibrils in a loose array and elastin, which facilitates blood flow by 
allowing the vessels to expand and contract. The middle layer (media) is composed of 
smooth muscle cells in an elastin-laden extracellular matrix. The inner layer (intima) is 
the single layer of vascular endothelial cells that is in direct contact with blood flow.  
  3 
Injury to the intima layer due to sheer forces in blood flow instigates the process 
of atherosclerosis by increasing the adhesiveness and permeability of vessel walls (Libby, 
2004; Ross, 1999; Santos & Nasir, 2009). In response, lipids flowing in the blood stream 
begin to accumulate as deposits on the intima. Chemical modifications to the lipid 
deposits results in endothelial dysfunction. Endothelial dysfunction triggers an 
inflammatory response, which causes (a) cytokines to increase expression of adhesion 
molecules on the intima and (b) leukocytes (e.g., monocytes) to adhere and then migrate 
into the intima to become macrophages and engulf lipid deposits before expanding to 
become foam cells. At this point, blood vessels are classified as having a fatty streak. 
Subsequently, lymphocytes (e.g., T-cells) signal smooth muscle cells to migrate from the 
media to the area of the developing lesion in the intima, which then secrete extracellular 
matrix components. Over time, this secretion can accumulate to form a complete fibrous 
cap over the lesion. Moreover, the foam cells undergo cellular death (apoptosis) releasing 
their lipid contents under the fibrous cap to form an extracellular lipid core in the lesion. 
The expansion of developing lesions is initially directed outwards toward the adventitia 
layer. However, as lesions progress, the artery is no longer able to remodel outward and, 
therefore, begins to protrude into the flow of blood, resulting in a narrowing of arteries. 
Calcification also occurs in atherosclerotic lesions, which hardens the blood 
vessels (Johnson, Leopold & Loscalzo, 2006). Evidence of calcification is detectable only 
in advanced lesions that have formed a lipid core (Stary et al., 1995). This is due to 
calcium deposits combining and growing inside the lipid core to form large structures, 
which can progress until the majority of a lipid core becomes calcified. Because calcium 
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deposits appear only in advanced lesions, detection of calcium deposits indicates the 
presence of more advanced atherosclerosis. 
The process of subclinical atherosclerosis progresses over many years, during 
which time individuals are asymptomatic (Libby, 2004). However, subclinical 
atherosclerosis can have life threatening consequences due to changing physiology. 
Specifically, the narrowing and hardening of blood vessels (a) impedes blood flow and 
reduces oxygen supply to tissues and (b) promotes increased velocity and turbulence of 
blood flow, which can cause lesions to rupture (Arroyo & Lee, 1999). When a lesion 
ruptures, a blood clot (thrombus) may develop at the site of the rupture (Stary et al., 
1995; Zipes, Libby, Bonow, & Braunwald, 2004). Thrombi can dislodge and become 
emboli, which are carried through the circulation and lodge at distant sites. Both thrombi 
and emboli can partially or completely block blood flow to regions of the heart or the 
brain. These processes can result in various clinical events, including heart tissue death 
(myocardial infarction), brain tissue death (stroke), insufficient blood flow to the heart 
(cardiac ischemia), and cardiac arrest. The occurrence of one or more of these events 
signifies the transition from subclinical atherosclerosis to clinical CVD. 
Measurement of Subclinical Atherosclerosis 
Empirical studies have utilized several measures of CVD, including indicators of 
clinical CVD (e.g., cardiac events) and subclinical atherosclerosis. A criticism of some 
cardiovascular behavioral medicine research is the use of “soft” measures (e.g., self-
reported CVD events), which lends results susceptible to subjective reporting biases 
(Steptoe & Whitehead, 2005). In contrast, the current study will examine two markers of 
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subclinical atherosclerosis: (1) carotid intima-media thickness (CIMT) and (2) coronary 
artery calcification (CAC). These noninvasive imaging technologies make it possible to 
detect and quantify early to late states of subclinical atherosclerosis (Santos & Nasir, 
2009). 
The first marker, CIMT, is a measure of the arterial wall thickening (Sharma, 
Blaha, Blumenthal, & Musunuru, 2009). In the assessment of CIMT, B-mode ultrasound 
equipment is used to assess the combined thickness of intima and media layers of the 
carotid artery, one of two major arteries on each side of the neck that supply blood to the 
head (Peters, den Ruijter, Bots, & Moons, 2012; Sharma et al., 2009). Although obtained 
from the carotid artery, CIMT measurements are positively associated with the extent of 
atherosclerosis in other vascular beds, including the coronary arteries (Mancini, Dahlof, 
& Diez, 2004). This measurement technique is used to detect early to late stages of 
subclinical atherosclerosis (Sharma et al., 2009).  
The second marker, CAC, quantifies the degree of calcification in the walls of the 
coronary arteries (Johnson et al., 2006). Although there are multiple ways to measure 
CAC, multi-detector computerized tomography (MDCT) is one noninvasive imaging 
method (Budoff et al., 2006). From MDCT images, CAC scores can be obtained by using 
the standardized Agatston scoring system (Johnson et al., 2006). Because calcification is 
detectable only in advanced stage lesions, this measurement technique is used to detect 
late stages of subclinical atherosclerosis. 
Both CIMT and CAC are considered to be excellent surrogate indicators of the 
extent of underlying atherosclerotic burden (Peters et al., 2012). These measures have a 
graded association with risk of CVD events (Lester, Eleid, Khandheria, & Hurst, 2009). 
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Moreover, evidence suggests CIMT and CAC predict CVD events, independent of 
conventional risk factors (Peters et al., 2012). CIMT and CAC also predict CVD events 
independently of one another (Hurst, Ng, Kendall, BS, & Khandheria, 2007; Santos & 
Nasir, 2009). 
Risk Factors for Cardiovascular Disease 
Research has identified non-modifiable and modifiable risk factors for CVD in 
the biological, psychological, and social domains (Booth-Kewley & Friedman, 1987). 
Non-modifiable risk factors include age, sex, race/ethnicity, and family history of CVD. 
The incidence of CVD increases with age (Cardi, Munk, Zanjani, Kruger, Schaie, & 
Willis, 2010). Additionally, men have a higher risk of CVD than women, although 
women have a higher risk of stroke (Roger et al., 2012). Regarding race/ethnicity, the 
incidence of CVD is highest among African Americans, followed by Caucasian 
Americans and Mexican Americans (Schiller, Lucas, Ward, & Peregoy, 2010). 
Modifiable risk factors also contribute to CVD, including hyperlipidemia, hypertension, 
diabetes, obesity, tobacco use, and physical inactivity (Ray, 2005; Everson-Rose & 
Lewis, 2005). Psychosocial factors, such as SLEs and depression, are emerging 
modifiable risk factors for CVD (Rozanski, Blumenthal, Davidson, Saab, & Kubzansky, 
2005). 
Although research has identified several CVD risk factors, these factors are 
understudied in racial/ethnic minorities (Kurian & Cardarelli, 2007). The available 
research suggests the prevalence of conventional risk factors (e.g., hypertension, 
hyperlipidemia, diabetes, and tobacco use) is higher in African Americans than in 
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Caucasian Americans; however, these risk factors predict CVD similarly in Caucasian 
and African Americans (Hozawa, Folsom, Sharrett, & Chambless, 2007; Kurian & 
Cardarelli, 2007). Therefore, it is plausible that the higher CVD risk of African 
Americans is, in part, attributable to the higher prevalence of conventional risk factors 
(Hozawa et al., 2007). Similarly, racial differences in prevalence and impact of emerging 
CVD risk factors (e.g., SLEs and depression) could also partially explain the elevated 
CVD risk of African Americans.  
Stressful Life Events and Cardiovascular Disease 
Stressful Life Events 
SLEs constitute any set of circumstances that signifies or requires change in a 
person's life pattern (Holmes & Rahe, 1967). SLEs can be classified into thematic 
domains, such as changes in marital, occupational, or health status (Oei & Zwart, 1986). 
SLEs can also be classified according to severity, chronicity, and period. Severity reflects 
the degree of disruption and distress that the SLE causes (Cohen, Kessler, & Underwood 
Gordon, 1997). Severity can range from small hassles causing minimal disruption and 
distress (e.g., traffic) to traumatic experiences causing major disruption and distress (e.g., 
sexual abuse and natural disasters; Kanner, Coyne, Schaefer, & Lazarus, 1981; Updegraff 
& Taylor, 2000). Chronicity reflects the persistence or recurrence of SLEs over time 
(Cohen et al., 1997). The two broad chronicity categories are discrete (isolated, transient 
SLEs) and chronic (SLEs that persist or recur for a prolonged period; Liu, 2013). Lastly, 
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period reflects when the SLE occurred. For example, SLEs can occur in childhood (< 18 
years old) or adulthood (≥ 18 years old). 
The two main methods for measuring SLEs are checklist and interview. Checklist 
measures ask respondents to identify the events they have experienced during a specific 
period (e.g., past year) from a standard list of SLEs (Cohen et al., 1997). Interviews use 
qualitative probes to illicit information about potential SLEs and are typically designed to 
capture more nuanced information, including severity and chronicity. Trained researchers 
use this additional information and interview rating guidelines to categorize SLEs on the 
various dimensions. 
Of relevance to the present study, there appears to be differential exposure to 
SLEs across racial/ethnic groups. In one study of a population-based sample, African 
Americans reported a greater number of negative life events, exposure to discrimination, 
and financial strain than Caucasian Americans (Williams et al., 1997). More recent 
research corroborates these findings (Schetter, Schafer, Lanzi, Clark-Kauffman, Raju, & 
Hillemeier, 2013). African American parents reported higher rates of everyday racism 
than Caucasian and Latino American parents. Moreover, chronic stress scores from a 
qualitative interview assessing demands in three life domains (family, partner, and 
neighborhood) were higher among African American parents than Caucasian American 
parents. 
Stress Response 
SLEs typically induce a stress response. Lazarus and Folkman (1984) formulated 
a top-down model of the stress response, which proposes that, when people experience 
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environmental events, they evaluate (1) whether the demands pose a potential threat and 
(2) whether they have sufficient adaptive capacities to adequately cope (Lovallo, 2005). 
If the demands are perceived as threatening and their coping resources are deemed 
inadequate, then the situation will be appraised as stressful. This perceived stressor can 
produce affective (e.g., negative emotions) and behavioral (e.g., substance use) changes, 
as well as physiologic changes.  
To understand the potential effect of SLEs on health, it is important to review the 
physiologic processes of the stress response. These physiologic changes include 
activation of the sympathetic nervous system, HPA axis, and immune system, which are 
intended to help an organism adapt to the perceived threat (Glaser & Kiecolt-Glaser, 
2005). Activation of these systems involves a cascade of physiologic events described 
below (Gold & Chrousos, 2002).  
Activation of the sympathetic nervous system involves the sympathetic–adrenal–
medullary (SAM) axis (Lovallo, 2005). This pathway originates in the hypothalamus and 
brainstem and signals the adrenal medulla to release catecholamines (i.e., epinephrine and 
norepinephrine), which initiate the fight-or-flight response. This promotes further 
physiologic changes, including release of fuel stores from adipose tissue and the liver, 
increases in cardiac output and respiration rate, dilation of peripheral blood vessels, and 
enhancement of skeletal muscle contraction.  
Activation of the HPA axis begins with the release of corticotrophin-releasing 
factor (CRF) from the hypothalamus. CRF stimulates the release of norepinephrine, 
which in turn promotes the release of adrenocorticotropic hormone (ACTH) from the 
anterior pituitary (Gold & Chrousos, 2002). ACTH stimulates the secretion of 
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glucocorticoids (e.g., cortisol), mineralocorticoids, and androgens from the adrenal 
cortex. Increased concentrations of cortisol, in turn, increase blood glucose 
concentrations through gluconeogenesis (formation of glucose from smaller molecules) 
and glycogenolysis (breakdown of glycogen to form glucose). 
Activation of the immune system also occurs in response to stress (Gu et al., 
2012; Marslanda, Bachenb, Cohen, Rabind, & Manuck, 2002). Evidence suggests that 
sympathetic and HPA axis responses to stress are involved in the regulation of the 
immune system response (Lovallo, 2005). Specifically, norepinephrine secretion 
promotes the release of several cytokines, which activate the synthesis of acute phase 
response proteins, cell adhesion molecules, and fibrinogen (Vale, 2005). This culminates 
in an acute proinflammatory response (Vale, 2005). Cortisol released by the HPA axis, 
however, down-regulates this proinflammatory response (Vale, 2005). 
The acute stress response can be adaptive when allostasis returns these systems 
back to a balanced state of homeostasis (Chrousos & Gold, 1992). However, if the stress 
response persists, this results in sustained sympathetic and HPA axis activation (Chrousos 
& Gold, 1992). Under chronic stress, the proinflammatory effects of sympathetic 
activation can surpass anti-inflammatory effects of HPA axis activation (Vale, 2005) 
because immune cells become less sensitive to cortisol over time due to downregulation 
(Cohen et al., 2012; Black & Garbutt, 2002). This can result in exaggerated and 
prolonged inflammatory responses, which can ultimately lead to a chronic, low-grade 
inflammatory state among people experiencing chronic stress (Black & Garbutt, 2002).  
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Stressful Life Events and Cardiovascular Disease 
Empirical evidence suggests that SLEs are involved in the development and 
progression of CVD. For example, multiple studies have reported that adults with chronic 
occupational or marital stress have a two to three times higher risk of cardiac events 
(Thomas, Nelesen, Ziegler, Bardwell, & Dimsdale, 2004; Matthews & Gump, 2002). 
However, results in this area are inconsistent. A 15-year prospective study of a national 
representative sample found no associations between accumulated childhood, adulthood, 
and work SLEs and the onset of CVD (Andersen, Diderichsen, Kornerup, Prescott, & 
Hulvej Rod, 2011). In another population-based sample, SLEs were associated with an 
increased risk of stroke but not myocardial infarction (Kornerup, Osler, Boysen, 
Barefoot, Schnohr, & Prescott, 2010). The mixed findings regarding the relationship 
between SLEs and CVD could be due to inconsistent measurement of SLEs, including 
the degree of subjectivity captured by the measure (e.g., event counts verses perceived 
stress; Everson-Rose & Lewis, 2005) and the type of SLE under investigation (e.g., 
occupational SLEs versus any SLEs; Bunker et al., 2003). 
Other studies have linked SLEs to measures of subclinical atherosclerosis, 
including CIMT and CAC (Rozanski et al., 2005; Matthews, 2005). Many studies in this 
area have found that stressful work conditions, characterized by high demand and low 
decisional latitude, are related to increased CIMT (Everson, Lynch, Chesney, 1997; 
Kamarck et al., 2004; Muntaner et al., 1998; Nordstrom, Dwyer, Merz, Shircore, & 
Dwyer, 2001; Rosvall et al., 2002). Discrimination, another form of stress, may also have 
an impact on subclinical atherosclerosis. Specifically, in a study of African American 
women, chronic exposure to everyday discrimination was associated with a greater 
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likelihood of CAC (Lewis et al., 2006). The impact of SLEs on CAC, however, is 
inconsistent across studies. A prospective study of U.S. Army personnel found that the 
number and severity of SLEs did not predict the presence of CAC (O’Malley, Jones, 
Feuerstein, & Taylor, 2000). 
Several physiologic and behavioral mechanisms may explain the relationship 
between SLEs and subclinical atherosclerosis. Stress-related physiologic changes can 
promote atherosclerosis (Black & Garbutt, 2002). Specifically, the stress hormones 
released by the sympathetic nervous system and HPA axis increase cardiovascular 
activity and vasoconstriction, both of which can damage the endothelium (Joynt et al., 
2003). Moreover, catecholamines increase coagulation by activating blood clotting 
factors and platelets, and HPA axis hormones (e.g., cortisol) promote the development of 
CVD risk factors, including insulin resistance, visceral fat deposition, and hypertension 
(Gold & Chrousos, 2002; Joynt et al., 2003). Lastly, exaggerated and prolonged 
inflammatory responses to stress can lead to: (a) increased secretion of inflammatory 
mediators by vascular endothelium, (b) increased expression of cellular adhesion 
molecules, (c) increased uptake of lipids into macrophages, (d) decreased cell division, 
survival, and function, reducing the efficiency of the immune response, and (e) increased 
activation of vascular smooth muscle cells (Vale, 2005). In addition to physiologic 
mechanisms, SLEs are associated with worsening health behaviors, including increases in 
smoking, decreases in exercise (Dimsdale, 2008), and increases in the consumption of 
energy dense foods, which are high in sugar and fat (Torres, Susan, & Nowson, 2007). 
However, the relationship between SLEs and atherosclerosis persists after adjustment for  
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these health behaviors (Brotman, Golden, & Wittstein, 2007). Therefore, it is likely that 
both physiologic and behavioral mechanisms explain the link between SLEs and CVD 
(Dimsdale, 2008).  
The impact of SLEs on CVD may be particularly pronounced among African 
Americans. Evidence suggests that African Americans have increased exposure to SLEs 
(Schetter, et al., 2013; Williams et al., 1997). Furthermore, due to socioeconomic 
inequalities, African Americans may have fewer resources to effectively cope with SLEs 
and, thus, be especially vulnerable to their cardiotoxic effects (Geronimus, Hicken, 
Keene, & Bound, 2006). Supporting this notion, a study comparing African American 
and Caucasian women revealed that chronic stress scores related to higher CIMT in 
African Americans only (Troxel, Matthews, Bromberger, & Sutton-Tyrrell, 2003). 
Depression and Cardiovascular Disease 
Depression 
Depressive disorders are common conditions that impact a person’s mental and 
physical functioning (Pratt & Brody, 2008). The lifetime prevalence of major depressive 
disorder and dysthymic disorder is 16.2% and 6%, respectively (American Psychological 
Association, 2000; Kessler et al., 2009). Symptoms of depressive disorders are depressed 
mood, loss of interest/pleasure, appetite or weight changes, sleep disturbances, 
psychomotor retardation/agitation, feelings of worthlessness or guilt, fatigue, 
concentrations problems, and suicidal ideation (American Psychological Association, 
2000). For a diagnosis of major depressive disorder, five or more of these symptoms are 
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required. In addition, at least one of the symptoms must be either depressed mood or loss 
of interest/pleasure, and the symptoms must cause significant distress or impairment 
nearly every day over a 2-week period. 
Depression can be conceptualized as a dichotomous variable (presence/absence of 
a depressive disorder) or a continuous variable (severity of depressive symptoms). The 
presence/ absence of a depressive disorder is typically determined through the use of a 
structured clinical interview, such as the Depression Interview and Structured Hamilton 
(DISH; Freedland et al., 2002). In contrast, depressive symptom severity is usually 
assessed by self-report questionnaires, such as the Center for Epidemiologic Studies 
Depression Scale (CES-D) (Radloff, 1977) and the Beck Depression Inventory (Beck, 
Ward, Mendelson, Mock & Erbaugh, 1961).  
Depression and Cardiovascular Disease 
Prospective studies indicate that adults with depressive disorders or elevated 
depressive symptoms are at increased risk of developing CVD (Matthews, 2005; Joynt, 
Whellan, & O’Connor, 2003). Of note, the evidence supports a graded relationship 
(Rosanski, 1999). To illustrate, minor depression is associated with a 1- to 2-fold increase 
in risk of CVD, and major depression is associated with a 3- to 5-fold increase in risk 
(Bunker et al., 2003). The risk conferred by major depression is comparable to that of 
conventional CVD risk factors (Bunker et al., 2003). 
Although most studies have examined risk of clinical CVD, there is also 
considerable research linking depression to subclinical atherosclerosis. In a prospective 
study of healthy, older adults, higher depressive symptoms predicted greater 3-year 
  15 
increases in CIMT, even after adjustment for conventional risk factors, medication use, 
medical conditions, and other correlated negative emotional factors (Stewart, Janicki, 
Muldoon, Sutton-Tyrrell, & Kamarck, 2007). There is also evidence indicating that 
depression is associated with CAC or predicts the onset of CAC in generally healthy 
samples (Haas et al., 2005; Janssen et al., 2011; Matthews, Chang, Sutton-Tyrrell, 
Edmundowicz, & Bromberger, 2010; Stewart et al., 2012). For instance,  
Janssen et al. (2011) found that elevated depressive symptom severity at baseline was 
associated with 2-year progression of CAC in a sample of healthy women. 
Depression has been associated with physiologic and behavioral factors that 
promote atherosclerosis, all of which are mechanisms that may underlie the depression-
CVD relationship (Joynt et al., 2003; Grippo & Johnson, 2009). For instance, depression 
has been linked with metabolic syndrome, HPA axis dysregulation, autonomic nervous 
system dysfunction, systemic inflammation, and platelet hyperactivation. Depression has 
also been associated with poor health behaviors, such as smoking, physical inactivity, and 
noncompliance with medical recommendations intended to prevent CVD (Berntson, K. 
R. Stewart, Vrany, Khambaty, & J. C. Stewart, 2015). 
The impact of depression on CVD may vary by race/ethnicity. For example, 
Davidson and colleagues (2000) followed 3,340 individuals in the Coronary Artery Risk 
Development in Young Adults (CARDIA) study. Results indicated that those with 
elevated CES-D scores (≥16) had a higher incidence of hypertension five years later. The 
strength of this relationship was the greatest in African Americans. Additional research 
suggests the relationship between depression and atherosclerosis may be moderated by 
race. In a study by Lewis et al. (2009), the association between depressive symptoms and 
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aortic calcification was detected in African American but not Caucasian women. Taken 
together, these results suggest that African Americans may be particularly vulnerable to 
the cardiotoxic effects of depression. 
Depression and Stressful Life Events 
A large body of literature suggests that SLEs play a causal role in many instances 
of depression (Hammon, 2005). Recently, however, there has been increasing interest in 
the transactional nature of the SLEs-depression association, with more recent research 
indicating a bidirectional relationship. Specifically, depression may also create more 
SLEs. Moreover, the SLEs-depression relationship appears to change over time, as 
recurrent depressive episodes appear to be more independent of SLEs than first 
depressive episodes. Further research is needed to elucidate the complex relationship 
between SLEs and depression. In particular, depressive symptoms have the potential to 
impact the appraisal of SLEs, as well as the physiologic and behavioral responses to 
SLEs. 
Depression as a Potential Moderator of the Relationship Between Stressful Life Events 
and Cardiovascular Disease 
As previously noted, exposure to SLEs is an emerging risk factor for CVD. 
However, the magnitude and/or duration of physiologic and behavioral responses elicited 
by these events may be more pronounced for certain individuals. One potential moderator 
of the SLE-CVD relationship is depression. Specifically, individuals with depression may 
  17 
exhibit altered physiologic and behavioral responses to SLEs (Joynt et al., 2003), which 
may accelerate the development and progression of CVD.  
Depression-Related Dysregulation of Physiologic Stress Response Systems 
It has been proposed that depressed persons have exaggerated responses 
(reactivity) to stress and a slower return to baseline (recovery) following stress 
(Rozanski, Blumenthal, & Kaplan, 1999). This exaggerated reactivity and delayed 
recovery can manifest across multiple systems, including the sympathetic nervous 
system, HPA axis, and inflammatory branch of the immune system (Brotman et al., 2007; 
Gu, Tang & Yang, 2012; Vale, 2005). The following sections summarize research 
examining whether depression moderates stress-related responses of these systems.  
Depression and the Sympathetic Nervous System Response to Stress 
Light and colleagues (1998) examined the relationship between BDI scores and 
norepinephrine and cardiovascular responses to laboratory speech and postural stressors. 
Women with higher versus lower depressive symptoms had an increased heart rate and 
norepinephrine response to the speech stressor but not the postural stressor. These 
findings were extended by Gold and colleagues (2004), who investigated epinephrine 
responses to a laboratory speech stressor in healthy women. These women were classified 
into two groups based on a median split of BDI scores. There were no group differences 
in epinephrine reactivity immediately after the stressor. However, at 15 and 30 minutes 
post-stressor, the high depression group had elevated epinephrine levels relative to the 
low depression group. To summarize, the available evidence suggests that depression 
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may delay sympathetic recovery from stress, and there is mixed evidence as to whether 
depression increases sympathetic reactivity to stress.  
Depression and the Hypothalamic-Pituitary-Adrenal Axis Response to Stress 
Burke et al. (2005) conducted a meta-analysis of seven studies examining the 
association between depression and cortisol responses to psychological laboratory 
stressors. No difference in cortisol reactivity was detected between depressed and 
nondepressed participants. However, an analysis of the four studies that included cortisol 
recovery measures revealed that depressed participants had higher cortisol levels than 
nondepressed participants during recovery periods (more than 25 minutes after stressor 
offset). These findings suggest that depressed individuals may exhibit delayed HPA axis 
recovery from stress but not exaggerated reactivity to stress.  
Depression and the Inflammatory Response to Stress 
Evidence of the potential moderating effect of depression on inflammatory 
responses to stressors has been reported in two studies. The first study examined levels of 
interleukin-6 (IL-6), lymphocyte subsets, and DNA binding of nuclear factor kappa B (a 
transcription factor in the inflammatory signaling cascade) before and after a laboratory 
stressor in healthy men (Pace et al., 2006). Half of these participants had current major 
depressive disorder and increased early life stress (n = 14), and half were not depressed (n 
= 14). The depressed participants with increased early life stress had greater elevations in 
inflammatory markers (IL-6 and DNA binding nuclear factor kappa B) in response to a 
speech stressor than the nondepressed participants. Moreover, these inflammatory 
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responses were positively correlated with depressive symptom severity but not early life 
stress. This study suggests that inflammatory reactivity to stress may be exaggerated in 
depressed men. A second study corroborates these findings in 72 women, half whom met 
diagnostic criteria for a depressive disorder (Miller, Rohleder, Stetler, & Kirschenbalm, 
2005). Inflammatory marker levels (IL-6 and tumor necrosis factor-α) were assessed in 
blood samples exposed to dexamethasone, a corticosteroid that inhibits production of 
inflammatory markers. At baseline, women with depression had higher sensitivity to the 
anti-inflammatory effects of dexamethasone than women without depression. However, 
after exposure to a job interview stressor, depressed women’s sensitivity to 
dexamethasone declined while the controls' sensitivity increased. These results suggest 
that, under stress, depression is associated with resistance to hormones that terminate the 
inflammatory response, which could lead to prolonged inflammatory responses to 
stressors (i.e., delayed recovery). Altogether, findings from these studies suggest that 
depressed persons may have exaggerated and prolonged inflammatory responses to 
stress. 
Depression-Related Maladaptive Coping Responses to Stress 
In addition to physiologic responses, it is possible that depression alters 
behavioral responses to stress. For instance, depressed persons are more likely to use 
avoidance coping strategies in an attempt to deal with stressors than nondepressed 
persons (Felsten, 1997). Avoidance coping refers to attempts to avoid actively 
confronting a problem (distraction, denial, social diversion, behavioral disengagement) or 
to indirectly reduce emotional tension by eating or using substances, including tobacco 
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and alcohol (Holahan & Moos, 1987; Ingledew & Hardy, 1996). In a recent meta-
analysis, depression was found to have a moderate positive association with avoidance 
coping (r = .48; Aldao, Nolen-Hoeksema, & Schweizer, 2010). Use of avoidance coping 
strategies may partially explain depressed persons increased baseline levels of tobacco 
use and consumption of low-nutrient, energy dense foods (Strine, Mokdad, & Dube, 
2008). Therefore, during or following stressors, depressed individuals may be more likely 
to engage in poor health behaviors that could accelerate the development and progression 
of CVD. 
The Present Study 
Although both SLEs and depression have been associated with subclinical 
atherosclerosis and an increased risk of CVD events, most studies in these literatures 
have examined SLEs and depression in isolation, even though these factors may act 
together to influence CVD outcomes. Accordingly, the purpose of the present study was 
to examine whether depressive symptoms moderate the relationships between SLEs in 
adulthood and subclinical atherosclerosis (CIMT and CAC) in a community sample of 
African American adults. If it is found that exposure to SLEs is a stronger risk factor for 
CVD in African Americans with higher depressive symptoms, it would identify this 
group as one that is particularly vulnerable to the cardiotoxic effect of SLEs. 
Figure 1 presents the conceptual model guiding the present study, and Figure 2 
shows the hypothesized relationships among the variables examined in this study. To 
evaluate the model shown in Figure 2, I will test the following hypotheses: 
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1. SLEs will be positively associated with the degree of subclinical 
atherosclerosis. 
2. Depressive symptom severity will be positively associated with the degree of 
subclinical atherosclerosis. 
3. Depressive symptom severity will moderate the relationship between SLEs 
and CVD such that SLEs will be more strongly associated with subclinical 
atherosclerosis among African Americans with elevated depressive symptoms 
versus those with minimal or no symptoms. 
Because measures of SLEs, depression, and subclinical atherosclerosis were 
obtained from a community sample of African Americans, data from the AAH-Heart 
study provide a good opportunity to test the aforementioned hypotheses. 
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METHOD 
Study Sample 
This thesis used data from AAH-Heart study, which involves a subsample of the 
AAH parent study. The AAH parent study is a prospective cohort study of 998 African 
Americans aged 49-65 years living in the St. Louis metropolitan area. The recruitment 
rate for this study was 76%. Two areas of the city – a poor, inner-city location and a 
suburban location northwest of the city – were sampled. This AAH cohort underwent 
seven waves of assessments over nine years from 2000 to 2009. 
Between 2009 and 2011, AAH participants still participating as of 2009 (N = 735) 
were contacted by telephone or e-mail. Of those contacted, 430 (58.5%) did not 
participate in the AAH-Heart study for the following reasons: declined participation (n = 
152); unable to contact (e.g., disconnected or wrong telephone numbers; n = 246); 
relocated outside the St. Louis metropolitan area, institutionalized, or incarcerated (n = 
26); or death since 2009 (n = 6). The remaining 305 (41.5%) were enrolled in the AAH-
Heart study. Sampling weights and propensity score re-weighting adjustments for 
differential participation in the AAH-Heart study allows the cohort to approximate a 
population sample of the non-institutionalized African Americans from the AAH 
geographical areas according to the 2000 census. However, these sample weights and 
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propensity score re-weighting adjustments were not utilized in this current study, as the 
analyses approach chosen (PROCESS; see Data Analyses section) does not allow for 
these adjustments.  
From the participants enrolled in the AAH-Heart study (N = 305), I removed 3 
respondents with known dementia because this condition would likely interfere with the 
retrospective reporting of SLEs and depressive symptoms. I then excluded respondents 
with missing data for SLEs (n = 9), 17-item Hamilton Rating Scale for Depression 
(HAM-D-17) (n = 2), education (n = 1), high density lipoprotein cholesterol (HDL-C) (n 
=1), and antidepressant use (n = 2), leaving a sample of 287 older adults. From this 
sample, I removed 13 respondents with missing data for carotid intima-media thickness 
(CIMT) to create the CIMT cohort (N = 274) and separately removed 8 respondents with 
missing data for coronary artery calcification (CAC) to create the CAC cohort (N = 279). 
These two final cohorts had complete data on all variables utilized in primary hypothesis-
testing analyses. 
For hypothesis-testing analyses utilizing the alternate depression variable (Center 
for Epidemiologic Studies Depression Scale – Short Form (CES-D-SF)), additional 
respondents were excluded. For the CIMT cohort, 21 respondents were excluded for 
missing data for the CES-D-SF, leaving 253 respondents. For the CAC cohort, 22 
respondents were excluded for missing CES-D-SF data, leaving 257 respondents. 
For exploratory analyses, additional respondents were excluded. For the CIMT 
cohort, 13 respondents were excluded for missing data for number of fruit and vegetable 
servings, and 12 were excluded for missing data for C-reactive protein, leaving 249 
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respondents. For the CAC cohort, 14 respondents were excluded for missing 
fruits/vegetable servings data, and 12 were excluded for missing C-reactive protein data, 
leaving 253 respondents. 
The AAH-Heart study was a collaborative endeavor between three institutions: 
Washington University School of Medicine, Saint Louis University School of Medicine, 
and Indiana University School of Medicine. AAH-Heart was approved by ethics 
committees at all three institutions, and written informed consent was obtained from all 
participants. 
Measures 
Independent variable 
Life Events Calendar (LEC) 
To assess SLEs, the AAH-Heart investigators created the LEC by combining 
several standardized approaches to life events interviewing. The rationale for creating a 
new instrument was that all existing interviews and self-report inventories lacked 
comprehensiveness, as determined following a review of available materials. These 
investigators attempted to address this limitation by creating a more comprehensive 
measure. The LEC is a structured interview comprised of open-ended questions which 
gather data related to past stressful life experiences. Participants were questioned about 
recent SLEs (past 6 months), other SLEs in adulthood, and then SLEs in childhood. 
During all phases of inquiry, domains of SLEs were used as cues to recall stressful 
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experiences (e.g., Any stressful changes in your living situation?). Based on 
predetermined criteria (see Appendix), interviewers rated the reported events in terms of 
severity (1 = somewhat stressful, 2 = very stressful, 3 = extremely stressful or traumatic), 
chronicity (chronic = stressor lasted months or years, discrete = stressor lasted no more 
than a few hours, days, or weeks), period (adulthood = event occurred during or after age 
18, childhood = event occurred before age 18, recent = event occurred within the past 6 
months), and domain (76 category codes within the following domains: medical illnesses, 
injuries, or medical care; stressful changes in living arrangement; financial, work, or 
school-related problems; non-family relationship problems; marital relationships; family 
relationships; violence or trauma; and childhood).  
For this study, a SLE score was computed for each participant as the count of all 
events (across all domains) that had codes of 2-3 on severity, chronic or discrete for 
chronicity, and adulthood for period. Events with severity ratings of 1 were excluded so 
that the SLE score was not driven by more minor events (Monroe, 2008). Recent SLEs 
were excluded because these stressors may not have had enough time to promote 
atherosclerosis. Childhood SLEs were excluded, given that responses to these events are 
less likely to be moderated by depression because they are more likely to precede 
depressive symptom onset. Psychometric information (such as interrater reliability and 
construct validity) is not available for the LEC because it was created for this study. 
However, interview-based methods are the current gold standard for assessing SLEs 
(Monroe, 2008).  
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Dependent variables 
Carotid Intima-Media Thickness (CIMT) 
To obtain measures of the thickness of the intima and media layers of the carotid 
artery, bilateral ultrasound imaging was performed using a 9-MHz linear array transducer 
of the extracranial carotid artery at the common carotid artery, approximately 1 cm 
proximal to the carotid bifurcation. Procedural details are described elsewhere (Stein et 
al., 2008). CIMT was measured with an automated edge detection system (AMS; 
Wendelhag, Liang, Gustavsson, & Wikstrand, 1997). This system derived a continuous 
CIMT variable: the average intima-media thickness of the far wall of the right and left 
common carotid arteries, while excluding raised lesions and plaques. 
Coronary Artery Calcification (CAC) 
To obtain measures of coronary, carotid, and thoracic aorta calcification, 
participants were examined using a 64-slice dual-source multi-detector computerized 
tomography (MDCT) scanner (Somatom Sensation 64, Siemens, Forchheim, Germany). 
Scan parameters included: 24×1.2 mm collimation, 1.5 mm slice thickness, 0.37 second 
rotation time, spiral mode, 120 kilovoltage, and 80 mAs. Cardiac-pulsing imaging 
reduced radiation exposure and cardiac motion. Scans were acquired during a single 
breath-hold at the end of expiration (~5-15 second duration). Images derived from the 
MDCT were then analyzed for coronary calcium scores/volume. Intra- and inter-reader 
intraclass correlation coefficients for coronary calcium scores/volumes were ≥ 0.82 and ≥ 
0.97, respectively, in the laboratory used for this analysis. Coronary calcium scores were 
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quantified by standard Agatston scoring, determined by the density and area of identified 
calcified plaques, which is described in detail elsewhere (Budoff et al., 2006). For the 
present study’s CAC variable, total Agatston scores were dichotomized into the presence 
(total Agatston score > 0) or absence (total Agatston score = 0) of calcification. 
Moderator variables 
17-item Hamilton Rating Scale for Depression (HAM-D-17) 
A semi-structured interview, the Depression Interview and Structured Hamilton 
(DISH), was used to diagnose depressive disorders according to DSM-IV criteria and 
assess depressive symptom severity (Freedland et al., 2002). The DISH is comprised of 
three sections: optional opening questions to build rapport, current depression symptoms 
to aid in diagnosis and severity ratings of depression and depressive subtypes as well as 
comorbid anxiety disorders (generalized anxiety and panic disorders), and psychiatric 
history to capture lifetime and family history information. A DISH form, the DSM-IV 
Diagnosis Guide, enables the interviewer to quickly determine whether the diagnostic 
criteria are met for major depression, minor depression, and/or dysthymia. In a validation 
study, the DISH had 88% diagnostic overlap with a major depressive disorder diagnosis 
according to the Structured Clinical Interview for DSM-IV, which is the current gold 
standard of diagnostic interviews (Freedland et al., 2002). Additionally, in the Enhancing 
Recovery in Coronary Heart Disease (ENRICHD) study, clinicians' diagnoses, made by 
listening to tapes of DISH interviews, agreed with 93% of research nurse’s diagnoses 
made using the DISH (Freedland et al., 2002).  
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Depressive symptom severity was determined from the embedded 17-item 
Hamilton Rating Scale for Depression (HAM-D-17; Hamilton, 1960) using the 
Structured Interview Guide for the Hamilton Depression scale (SIGH-D; Williams, 
1988). This guide was created to increase the reliability of the HAM-D-17 when used by 
lay interviewers. The symptoms are defined by anchor-point descriptions, and raters 
consider both the intensity and frequency of a symptom when assigning it a value of 0-2, 
0-3, or 0-4. The scale yields a total score ranging from 0 to 52, with higher scores 
indicating more severe symptoms of depression. The SIGN-D version, which was used in 
the AAH-Heart study, has demonstrated good inter-rater reliability (r = 0.81; Williams, 
1988). The primary depression variable for this study was this HAM-D-17 score. 
Center for Epidemiologic Studies Depression Scale – Short Form (CES-D-SF)  
An 11-item self-report measure, the short form of the CES-D, was also used to 
assess the severity of depressive symptoms (Kohout, Berkman, Evans, & Cornoni-
Huntley, 1993). For each item of the CES-D-SF, participants indicated how often they 
experienced various symptoms during the last week using a scale ranging from 0 (rarely 
or none of the time) to 3 (most or all of the time). Total scores can range from 0 to 33, 
with higher scores indicating greater depressive symptom severity. The CES-D-SF has 
demonstrated good internal consistency (Cronbach’s α = .76-.81), as well as strong 
correlations with clinician ratings and other self-report measures of depression (Radloff, 
1977; Weissman, Sholomskas, Pottenger, Prusoff, & Locke, 1977). 
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Covariates 
Given their associations with SLEs, depression, and atherosclerosis, a number of 
potential confounders were included in the models as covariates. First, the following self-
reported demographic factors were included: age, sex, and years of education. Second, 
the biomedical factors that were included are self-reported diabetes (yes = 1, no = 0) 
assessed through a self-report index of medical comorbidities (Charlson Comorbidity 
Index; Charlson, Pompei, Ales, & MacKenzie, 1987); echocardiography derived mean 
arterial pressure; fasting low density lipoprotein cholesterol (LDL-C), high density 
lipoprotein cholesterol (HDL-C), and hemoglobin A1c (HbA1c); measured body mass 
index (BMI; Huxley, Mendis, Zheleznyakov, Reddy, & Chan, 2010; Takami et al., 2001); 
and self-reported current use of antihypertensive medications, lipid-lowering 
medications, diabetes medications, and antidepressants (yes = 1, no = 0). 
Potential Mediators 
Given that a number of physiologic and behavioral factors may mediate the SLEs 
to atherosclerosis relationship moderated by depression, I identified a number of these 
potential mediators which were used in exploratory moderated mediation analyses. 
Potential mediators measured are current tobacco use (0 = no, 1 = yes), number of daily 
fruit and vegetable servings (CDC Questionnaire – 6 items; Center for Disease Control 
and Prevention, 2011), physical activity (International Physical Activity Questionnaire 
Short Form [IPAQ-SF] - 9 items; Lee, Macfarlane, Lam, & Stewart, 2011), and a 
biomarker for inflammation (C - reactive protein [mg/L]). 
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Procedure 
Participants in the AAH-Heart study attended data collection visits between June 
2009 and November 2011. During these visits, the assessments of SLEs, CIMT, CAC, 
depressive disorders and symptoms, demographic factors, biomedical factors, and 
potential mediator variables described above were performed. Additional assessments to 
measure factors not part of the present study were also completed (Bruchas et al., 2013). 
All assessment components were conducted and interpreted by trained personnel under 
the supervision of the study investigators. 
Data Analyses 
Data Cleaning 
Initial data cleaning procedures assessed for missing data, outliers, and normality 
for each variable. 
To check for systematic missingness in the dataset, age, sex, and education were 
examined as predictors of missing data. This check was completed by creating a 
dichotomous missingness variable for each variable (0 = no missing, 1 = missing). Then, 
age, sex and education were entered simultaneously into logistic regressions models 
predicting each missingness variable. I observed only one relationship: as age increased 
so did the likelihood of missingness on the CES-D-SF variable (OR = 1.14, 95% CI: 
1.01-1.28, p = 0.04). Because the CES-D-SF was not the primary depressive symptom 
severity measure, analytic procedures proceeded as planned. 
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To identify out-of-range values, I examined variable frequencies, and all variables 
were found to be within the plausible range. All outliers for continuous variables (z 
scores ≥ 3.3) in the data set were identified. The number of outliers for each variable was 
as follows: SLEs (n = 4), HAM-D-17 (n = 1), CES-D-SF (n = 1), education (n = 2), HDL-
C (n = 3), HbA1c (n = 4). The four outliers for the SLE variable were no longer outliers 
after winsorizing this distribution to address kurtosis (described below). All other outliers 
were not altered or deleted for three reasons: (1) these cases did not result in non-normal 
distributions, (2) some z scores ≥ 3.3 are expected when sample sizes are large, and (3) 
these cases are likely legitimate cases of the sample population (Tabachnick & Fidell, 
2001). 
Determining normality of variables included assessments of skewness (< 3.0) and 
kurtosis (< 10.0) (Kline, 1998). Because the distribution for SLEs violated the normality 
assumption (kurtosis = 15.3), I visually inspected it, which revealed positive skew and a 
number of outliers near the upper end of the distribution. Because these values are likely 
true values, I decided to winsorize this variable at the upper end by setting the top 5% of 
the values equal to the value corresponding to the 95th percentile. The HbA1c 
distribution also violated normality assumptions (skewness = 3.7, kurtosis = 20.3). This 
variable was log transformed, which normalized the distribution (skewness = 2.7, 
kurtosis = 9.0). After making these changes to the SLEs and HbA1c variables, deviations 
from normality across variables were insubstantial. 
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Software 
All analyses were conducted using SPSS statistical software (Version 20). I used 
SPSS linear and logistic regression to test the main effects models for Hypotheses 1 and 
2, and I used the SPSS Macros called PROCESS (Hayes, 2013) to test the moderation 
model for Hypothesis 3, as well as the exploratory mediation and moderated mediation 
models. PROCESS estimates the coefficients of a model using ordinary least squares 
regression for continuous outcomes or maximum likelihood logistic regression for 
dichotomous outcomes. Importantly, PROCESS uses bootstrapping, which is a 
nonparametiric approach to effect size estimation that uses resampling (MacKinnon, 
Lockwood, & Williams, 2004). Subsamples are selected from the original sample, with 
replacement, and the effect within each subsample is computed. This process is repeated 
thousands of times to estimate a sampling distribution for the effect of interest. From this 
distribution, upper and lower estimates of the effect can be identified, and a confidence 
interval can be computed. When this confidence interval does not contain zero, it can be 
concluded that the effect is statistically significant. Using this approach, PROCESS 
generates direct and indirect effects for mediation and mediated moderation models, 
conditional effects for moderation models, and conditional indirect effects for moderated 
mediation models. For the current study, effect size estimates are based on biased-
corrected 95% bootstrap confidence intervals with 10,000 bootstrap resamples.  
PROCESS bootstrapping is appropriate to use in the present study for three 
reasons. First, it does not require that the sampling distribution be normally distributed, 
which allows for testing moderation and mediation in cases where there is asymmetry in 
the distribution (Hayes, 2013; MacKinnon et al., 2004). Second, it has greater statistical 
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power than some approaches (e.g., Sobel test), while also minimizing the Type I error 
rate (Hayes, 2013; MacKinnon et al., 2004). Third, PROCESS bootstrapping has the 
ability to estimate the conditional effects in complex moderated mediation models, which 
are exploratory analyses in the present study (Preacher, Rucker, & Hayes, 2007). 
Regression Models 
For hypothesis-testing and exploratory analyses, a series of linear regression 
models (when CIMT was the dependent variable) and logistic regression models (when 
CAC was the dependent variable) were conducted. The first set of models was adjusted 
for the demographic factors (demographic-adjusted models), and the second set was 
further adjusted for the biomedical factors (fully-adjusted models).  
Test of Hypotheses 
To test Hypothesis 1, the SLEs measure was entered as the independent variable 
into models predicting CIMT or CAC. To test Hypothesis 2, one of the depressive 
symptom severity measures (HAM-D-17 or CES-D-SF) was entered as the independent 
variable into models predicting CIMT or CAC. The depressive symptom severity 
measures were examined in separate models.  
To test hypothesis 3, I used Model 1 in the PROCESS Macro for SPSS to conduct 
moderated multiple regressions (Hayes, 2013). This model was constructed to test the 
conditional effect of SLEs on subclinical atherosclerosis based on depressive symptom 
severity. For these models, SLEs was entered as the independent variable (X) and CIMT 
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or CAC as the outcome variable (Y). One of the depressive symptom severity measures 
was entered as the moderator variable (W) in separate models. 
Exploratory Analyses 
Moderated Mediation 
In exploratory analyses, I planned to explore several candidate mechanisms (i.e., 
tobacco use, fruit and vegetable consumption, physical activity, and C-reactive protein) 
of the moderation effect of Hypothesis 3. Two of these potential mediators could not be 
analyzed and were excluded from these analyses. First, physical activity was excluded 
because a majority (n = 171) of the sample did not complete key components of the 
questionnaire (e.g., frequency or duration) required to calculate activity levels. Second, 
the dichotomous measure of tobacco use was excluded because PROCESS macros does 
not currently allow for categorical mediator variables (Hayes, 2013). Therefore, in this 
exploratory analysis, I tested whether number of daily fruit and vegetable servings and C-
reactive protein partially mediate the SLE by depressive symptom severity interaction 
predicting subclinical atherosclerosis. This moderated mediation is also called conditional 
process modeling (Preacher et al., 2007). I conducted these conditional process models 
using Model 7 of the PROCESS macro for SPSS (Hayes, 2013). Model 7 allows the 
indirect effect of an independent variable (X: SLEs) on a dependent variable (Y: CIMT or 
CAC) through mediators (M: fruit and vegetable consumption and C-reactive protein) to 
be moderated (W: HAM-D-17 or CES-D-SF). Both mediators were included in models 
simultaneously. In this moderated mediation model, the indirect effect through the 
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mediator is constructed as the product of the X → M effect, which is conditional on W, 
and the M → Y effect. In this Model 7, the “index of moderated mediation” is an 
inference about whether the indirect effect is moderated. The effects from initial models 
utilizing CIMT as the Y variable were smaller than the number of decimal places 
provided in the PROCESS outputs. Therefore, for these moderated mediation analyses, 
the units of the CIMT variable were converted from millimeters to micrometers. 
Alternative Mediation Model 
I also tested an alternative mediation model, which examined whether depression 
mediates the relationship between SLEs and subclinical atherosclerosis. I used Model 4 
in the PROCESS Macro for SPSS to conduct mediation multiple regressions (Hayes, 
2013). This model tests whether the indirect effect of SLEs on subclinical atherosclerosis 
(CIMT or CAC) through depressive symptoms severity (HAM-D-17 or CES-D-SF) is 
significant. For these models, SLEs was entered as the independent variable (X) and 
CIMT or CAC as the outcome variable (Y). One of the depressive symptom severity 
measures (HAM-D-17 or CES-D-SF) was entered as the mediator variable (M).  
Sensitivity Analyses 
For significant relationships, I had planned to rerun all analyses after excluding 
AAH-Heart participants with clinical (i.e., physician diagnosed) CVD to minimize 
concerns regarding reverse causality (i.e., clinical CVD leading to increased reports of 
SLEs and depressive symptoms). Because no significant relationships were detected, 
none of these sensitivity analyses was performed. 
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RESULTS 
Characteristics of Participants 
Descriptive statistics for the final cohorts (CIMT N= 274 and CAC N=279) are 
presented in Table 1. Participants’ ages ranged from 59-75 years, with a mean age of 66 
years. The cohorts were predominantly female, and the mean education level was 13 
years.  
In both cohorts, 17.5% of participants had a mean arterial pressure that is 
indicative of hypertension (≥ 107 mmHg; Carlsson, Johansson, Theobald, & Wändell, 
2013), and over 70% reported taking an antihypertensive medication. Concerning 
cholesterol variables, 7.3-7.9% of the participants had high LDL cholesterol (≥ 160 
mg/dL; National Institutes of Health, 1998), 4.7% had low HDL cholesterol (< 35 
mg/dL), and approximately 40% reported taking a lipid lowering medication. A total of 
30% reported a diabetes diagnosis, 28% had HbA1c values indicative of diabetes (≥ 
6.5%; World Health Organization, 2011), and 27% reported taking a diabetes medication. 
The mean BMI fell in the obese range (BMI ≥ 30 kg/m2). The average number of daily 
fruit and vegetable servings was 3.9-4.0, and the average C-reactive protein level was 
12.7-13.0 mg/L.
 
  37 
The range for the number of SLEs reported was 0 to 11, with a mean of 4.3-4.4. 
Mean HAM-D-17 and CES-D-SF scores fell in the no depression ranges; however, 22% 
had a HAM-D-17 score ≥ 8, and 18% had a CES-D-SF score ≥ 8, which are indicative of
clinically relevant depression (Levine, 2013; Zimmerman, Martinez, Young, Chelminski, 
& Dalrymple, 2013). Additionally, 11-12% of the participants reported taking an 
antidepressant medication. Concerning indicators of subclinical atherosclerosis, mean 
CIMT was 0.83 mm, and 70% of participants had CAC. 
Zero Order Correlations 
 Pearson’s r (r) zero order correlations between predictor (SLEs), moderator 
(HAM-D-17 and CES-D-SF), and outcome variables (CIMT and CAC) were computed in 
SPSS and are presented in Table 2. As would be expected, I found a strong positive 
association between the two depressive symptom measures (r = .75 for HAM-D-17 and 
CES-D-SF). These depressive symptom measures had weak to moderate positive 
relationships with SLEs (r = .35 [CIMT Cohort] and r = .34 [CAC Cohort] for HAM-D-
17 and SLEs; r = .25 for CES-D-SF and SLEs). There was a weak but significant 
relationship between measures of subclinical atherosclerosis (r = .75 for CIMT and 
CAC). Lastly, there were no significant zero order associations of psychosocial factors 
(SLEs, HAM-D-17, or CES-D-SF) with measures of subclinical atherosclerosis (CIMT or 
CAC). 
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Primary Results 
Tests of Hypotheses 1 and 2 
Regression models testing main effects of SLEs and depressive symptoms on 
CIMT or CAC revealed no significant effects (see Table 3). In demographic-adjusted 
models, number of SLEs was not associated with CIMT (p = 0.73) or CAC (p = 0.23). 
HAM-D-17 score was also not associated with CIMT (p = 0.30) or CAC (p = 0.39). As is 
shown in Table 3, a similar pattern emerged when substituting the secondary depressive 
symptom measure (CES-D-SF) for the HAM-D-17 in the models (p = 0.61 for CIMT and 
p = 0.21 for CAC). Finally, in fully-adjusted models, number of SLEs (p = 0.98 for 
CIMT and p = 0.16 for CAC), HAM-D-17 (p = 0.35 for CIMT and p = 0.77 for CAC), 
and CES-D-SF (p = 0.71 for CIMT and p = 0.34 for CAC) remained unrelated to CIMT 
and CAC. Thus, the results did not support Hypothesis 1 or 2. 
Test of Hypothesis 3 
Regression models testing the number of SLEs by depressive symptom 
interactions for CIMT or CAC revealed no significant effects (see Table 4). In 
demographic-models, the number of SLEs by HAM-D-17 interaction was not associated 
with CIMT (p = 0.69) or CAC (p = 0.50). This pattern of results remained the same in 
fully-adjusted models (p = 0.89 for CIMT and p = 0.69 for CAC) and in a parallel set of 
analyses testing the number SLEs by CES-D-SF interaction (demographic-adjusted 
models: p = 0.72 for CIMT and p = 0.25 for CAC; fully-adjusted models: p = 0.83 for 
CIMT and p = 0.38 for CAC). Therefore, the results did not support Hypothesis 3.   
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Exploratory Results 
Moderated Mediation Results 
In the moderated mediation models, I tested whether number of daily fruit and 
vegetable servings and C-reactive protein partially mediated the hypothesized interaction 
between SLEs and depressive symptom severity (HAM-D-17 or CES-D-SF) for CIMT 
and CAC. Across all models, there was no evidence of moderated mediation as 
determined by the index of moderated mediation, an inference about whether indirect 
effects are moderated by the depressive symptom measures. In demographic-adjusted 
models (N = 249), the index of moderated mediation for number of daily fruit and 
vegetable servings (Index = .0553, SE = .0636, 95% CI: -.0342 to .2257) and CRP (Index 
= -.0008, SE = .0627, 95% CI: -0.1410 to 0.1261) was not significant for CIMT (µm). 
The index of moderated mediation for number of daily fruit and vegetable servings 
(Index = -.0003, SE = .0007, 95% CI: -.0029 to .0006) and CRP (Index = .0000, SE = 
.0014, 95% CI: -.0027 to .0036) was also not significant for CAC (N = 253). In fully-
adjusted models and a parallel set of analyses substituting the CES-D-SF for the HAM-
D-17, all 95% confidence intervals for the index of moderation mediation contained zero, 
indicating that potential indirect effects were not moderated by the depression symptom 
measures. 
Alternative Mediation Model Results 
Regression models testing depressive symptom severity as a potential mediator of 
the SLE-subclinical atherosclerosis relationship revealed no significant indirect effects. 
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Number of SLEs was positively associated with HAM-D-17 (B = 0.6719, SE = 0.1087, 
95% CI = 0.4580 to 0.8859, p < .0001), which in turn was unrelated to CIMT (B = .0021, 
SE = .0017, 95% CI = -.0012 to .0054, p = 0.22). Number of SLEs was not indirectly 
related to CIMT through HAM-D-17 (point estimate of indirect effect = .0014, SE = 
.0012, 95% CI = -.0010 to .0040). 
Results were similar in models examining CAC. Once again, number of SLEs was 
positively associated with HAM-D-17 (B = 0.6602, SE = 0.1106, 95% CI = 0.4424 to 
0.8781, p <.0001), HAM-D-17 was not related to CAC (B = .0351, SE = .0509, 95% CI = 
-0.1797 to .0198 p = 0.19), and number of SLEs was not indirectly related to CAC 
through HAM-D-17 (point estimate of indirect effect = .0232, SE = .0186, 95% CI = -
.0097 to .0636). In fully-adjusted models and a parallel set of analyses substituting the 
CES-D-SF for the HAM-D-17, no significant indirect effects were observed. 
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DISCUSSION 
Summary of Findings 
The present study sought to determine whether depressive symptoms moderate 
the relationships between SLEs in adulthood and subclinical atherosclerosis in a 
community sample of older, African American adults. Three hypotheses were tested. The 
hypothesis (Hypothesis 1) that SLEs would be positively associated with the degree of 
subclinical atherosclerosis was not supported, as there were no significant relationships 
between number of SLEs and CIMT or CAC. In addition, the hypothesis (Hypothesis 2) 
that depressive symptom severity would be positively associated with the degree of 
subclinical atherosclerosis was not supported, given that no significant associations of 
HAM-D-17 or CES-D-SF with CIMT or CAC were observed. Lastly, the hypothesis 
(Hypothesis 3) that depressive symptom severity would moderate the relationship 
between SLEs and subclinical atherosclerosis was also not supported. Models testing the 
number of SLEs by depressive symptoms (HAM-D-17 or CES-D-SF) interactions 
revealed no significant effects for CIMT or CAC.  
Fit with Prior Literature 
Regarding the first hypothesis, the absence of an association between SLEs and 
subclinical atherosclerosis in African Americans adds to the existing mixed literature on 
  42 
this relationship. My results are consistent with those of by O’Malley and colleagues 
(2000), in which it was found that the number and severity of SLEs was not associated 
with CAC in U.S. Army personnel. However, my results conflict with a study by Troxel 
et al. (2003) that found that chronic stress scores were related to greater CIMT in African 
American women but not Caucasian women. Considering that (a) only two previous 
studies have examined a composite measure of SLEs in relation to subclinical 
atherosclerosis and (b) the findings of the study that examined racial/ethnic differences 
conflict with my results, it remains unclear as to the relationship between SLEs and 
subclinical atherosclerosis in African Americans. Notably, the previous study that 
observed a relationship in African Americans only used a female sample, whereas the 
present sample consisted of both men and women. In addition, the types of cumulative 
SLEs captured differed across measures in the current and previous studies, which may 
account for the inconsistent results (McQuaid et al., 1992). Specific types of stress (e.g., 
work stress and racial discrimination) have been found to be related to increased CIMT 
(Everson, Lynch, Chesney, 1997; Kamarck et al., 2004; Lewis et al., 2006; Muntaner et 
al., 1998; Nordstrom, Dwyer, Merz, Shircore, & Dwyer, 2001; Rosvall et al., 2002), 
suggesting that some types of SLEs may be more cardiotoxic than others.  
Concerning the second hypothesis, the absence of an association between 
depressive symptom severity and subclinical atherosclerosis conflicts with previous 
results. Findings from most studies in this literature support a positive prospective 
relationship between depressive symptoms and subclinical atherosclerosis, with increased 
depressive symptom severity predicting longitudinal increases in CIMT (Stewart et al., 
2007) and CAC (Haas et al., 2005; Janssen et al., 2011; Matthews, Chang, Sutton-Tyrrell, 
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Edmundowicz, & Bromberger, 2010; Stewart et al., 2012). Only one study, which was 
cross-sectional, did not detect such an association (O'Malley, Jones, Feuerstein, & 
Taylor, 2000). Although none of these investigations examined African American-only 
samples, studies have found (a) that relationships between depressive symptoms and 
subclinical atherosclerosis did not differ by race/ethnicity (Janssen et al., 2011; Stewart et 
al., 2012) and (b) that depressive symptom severity was related to CAC in African 
Americans but not Caucasians (Lewis et al., 2009). 
With respect to the third hypothesis, the lack of SLEs by depressive symptoms 
interaction effects is inconsistent with results from one of my previous studies utilizing 
data from 28,583 adults from the National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC) (Berntson & Stewart, 2014). In that study, a significant SLEs by 
depressive disorder interaction was found (OR = 1.20, 95% CI: 1.06-1.35, p < 0.01). 
Stratified analyses revealed that number of SLEs was a stronger predictor of incident 
CVD in adults with a lifetime depressive disorder (OR = 1.18, 95% CI: 1.10-1.27) than in 
adults without a lifetime depressive disorder (OR = 1.10, 95% CI: 1.07-1.14). Although it 
is presently unclear, several methodological differences may have contributed to these 
discrepant findings, including the study design (current study: cross-sectional; previous 
study: prospective), the study samples (current study: a local older, African American 
sample; previous study: a large sample representative of the U.S. population), the 
depression measures (current study: continuous symptom severity; previous study: 
dichotomous depressive disorder status), and the CVD measures (current study: CIMT 
and CAC; previous study: self-reported incident myocardial infarction, angina, or 
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arteriosclerosis). To my knowledge, no other studies have examined depressive symptom 
severity as a potential moderator of the SLE-CVD relationship. 
Possible Explanations for Null Findings 
The null findings of the present study (a) may reflect the true state of nature or (b) 
may be due to methodological issues preventing me from detecting the true state of 
nature (Kazdin, 2002). With respect to explanation (a), SLEs, depressive symptoms, and 
the SLEs by depressive symptoms interaction may be truly unrelated to subclinical 
atherosclerosis in African Americans. However, because the present results conflict with 
those of past studies (Hypothesis 1, 2 and 3; see preceding section) and there is a paucity 
of studies (Hypothesis 1 and 3), it is unclear if my null results reflect the true state of 
nature. In regards to explanation (b), a number of methodological issues (i.e., limitations) 
could also explain the null results. 
First, inappropriate study design could explain inconsistencies with prior literature 
(Kazdin, 2002). The present study was a cross-sectional examination of temporal 
hypotheses. I assumed that current depressive symptom severity, in part, reflects a stable 
trait that precedes SLEs and downstream subclinical atherosclerotic progression. 
However, this may not be the case. Rather, if SLEs occurred prior to the onset of 
depressive symptoms, then I would have missed the hypothesized moderation effect. 
Therefore, a prospective study design is needed to best evaluate my temporal hypotheses.  
Secondly, biased selection method could also explain inconsistencies with prior 
literature. Selection bias for the current study likely contributed to a relatively stable 
sample of participants (246/735 potential participants were unable to be contacted; 
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33.5%) with the time to participate (152/735 potential participants declined participation; 
20.7%). This stability and time to participate may reflect a relatively low-stress sample 
which may have restricted range on both SLEs and depressive symptoms measures. This 
theory is consistent with descriptive statistics of my sample: low number of SLEs 
reported (CIMT Cohort Mean = 4.4; CAC Cohort Mean = 4.3) and low levels on HAM-
D-17 (CIMT Cohort Mean = 5.2; CAC Cohort Mean = 5.2) and CES-D-SF (CIMT 
Cohort Mean = 4.7; CAC Cohort Mean = 4.7) depression measures. Therefore, the 
current study’s sample characteristics could have restricted range in the independent 
(SLEs) and moderating (depressive symptoms) variables which may have contributed to 
null results. 
Another methodological issue was that I was likely unable to capture some 
relevant SLEs with the current study’s SLEs measurement method. The interview-based 
method of assessing all lifetime SLEs likely captured only major SLEs which occur 
infrequently, whereas this method is less likely to have captured relevant daily hassles. 
Because the type of SLEs likely captured occur less frequent than daily hassles they also 
are likely to produce a less frequent impact on CVD. Effects may have been detected if 
frequent stressful events in daily life were the target of measurement. Consistent with this 
notion, research on types of stress which tend to occur frequently (e.g., work stress and 
racial discrimination) have been found to be related to increased CIMT (Everson, Lynch, 
Chesney, 1997; Kamarck et al., 2004; Lewis et al., 2006; Muntaner et al., 1998; 
Nordstrom, Dwyer, Merz, Shircore, & Dwyer, 2001; Rosvall et al., 2002). 
Another relevant methodological issue is possible error variance in the 
independent variable (Kazdin, 2002). The interview-based method used to assess SLEs 
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could introduce error variance through biased recall. First, the negative mood likely 
experienced by participants with depressive symptoms at the time of recall could have led 
to inflated reports of negative SLEs (Cohen, Towbes, & Flocco, 1988). Second, 
depression-related cognitive deficits may have reduced the accuracy of SLEs recall in 
participants with depressive symptoms (Brand, Jolles, & Gispen-de Wied, 1992). 
Another methodological limitation that may have contributed to null results is a 
restricted range in the dependent variables. Age is a strong predictor of subclinical 
atherosclerotic progression. Therefore, the older age of the current sample (mean age = 
66 years) may have restricted the range of the outcome variables, thereby making it more 
difficult to detect the hypothesized associations. Consistent with this idea, the degree of 
subclinical atherosclerosis in this sample (68.8% with CAC and mean CIMT of 0.83 mm) 
was higher than in previous studies utilizing younger samples [e.g., 58.8% with CAC 
(Lewis et al., 2009) and mean CIMT of 0.62 mm (Troxel et al., 2003) in CVD free 
African Americans].  
As a last methodological limitation, the present study was likely underpowered, 
especially for tests of Hypothesis 3, due to its small sample relative to traditional 
epidemiologic studies. Thus, I may have made a type II error. This seems less likely, 
however, because I utilized bootstrapping analyses that maximized power through re-
sampling and because no nonsignificant trends in the hypothesized directions were 
observed. 
While the present study does have important limitations, it also has several 
strengths. Notable strengths include: (1) a sample of African Americans, (2) an interview-
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based method of assessing SLEs, (3) multiple measures of depressive symptom severity 
and subclinical atherosclerosis, and (4) bootstrapping analyses that maximize statistical 
power.  
Recommendations for Future Research 
Although none of the hypothesized effects was detected, replication is needed 
before definitive evidence of absence can be claimed. This future research should 
include: (1) a prospective design to determine directionality of any observed 
relationships, (2) a good representation of African Americans and women to explore 
moderation by race/ethnicity and gender, (3) a larger middle-aged sample to ensure 
adequate power and maximize variability in measures of subclinical atherosclerosis, (4) 
assessments of multiple SLEs indicators (e.g. interview event counts and daily hassles) 
and depressive symptoms to examine their interactive effect, (5) assessments of multiple 
CVD outcomes, such as subclinical atherosclerosis and CVD events, to evaluate whether 
relationships change across the stages of the atherosclerotic process. Investigators should 
also consider performing separate analyses for men and women, given that there are 
gender differences in responses to stress (Matthews, Gump, & Owens, 2001), and for 
different types of SLEs, given that some SLEs may be more cardiotoxic than others 
(Bunker et al., 2003). Lastly, if effects are detected, investigators should examine 
mechanistic pathways that may underlie the interactive effect of SLEs and depressive 
symptoms on CVD outcomes (see Figure 1). 
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Conclusions 
In summary, results of this cross-sectional study utilizing data from the AAH-
Heart study suggest that SLEs, depressive symptoms, and their interaction are not 
associated with measures of subclinical atherosclerosis among older, African Americans 
adults. Because the current results are inconsistent with some past findings and there is a 
paucity of studies utilizing African American samples, future research is needed to 
examine the independent and interactive effects of SLEs and depressive symptoms on 
subclinical atherosclerosis and other CVD outcomes in this racial group. If my results are 
repeatedly replicated in studies with stronger methodology (see preceding section), it 
would suggest that SLEs, depressive symptoms, and their interactive effect do not 
promote atherosclerotic progression and clinical CVD among African American adults. 
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Table 1  
Participant Characteristics for the CIMT and CAC Cohorts 
Note. Continuous variables are presented as mean (standard deviation), and categorical 
variables are presented as percentage. HbA1c = hemoglobin A1c. SLEs = stressful life 
events. HAM-D-17 = 17-item Hamilton Rating Scale for Depression. CES-D-SF = 
Center for Epidemiologic Studies Depression Scale – Short Form. CIMT = Carotid 
Intima-Media Thickness. CAC = Coronary Artery Calcification.  
† Number of daily fruit and vegetable servings and C-reactive protein are based on 
reduced exploratory analysis samples: CIMT cohort N = 249 and CAC cohort N = 253. 
‡CES-D-SF scores are based on reduced sensitivity analysis samples: CIMT cohort N = 
253 and CAC cohort N = 257.  
Characteristic 
CIMT Group 
(n = 274) 
CAC Group 
(n = 279) 
Age, years 65.6 (4.2) 65.6 (4.1) 
Female, % 67.5 67.0 
Education Level (range: 1-25 years) 13.4 (2.9) 13.4 (2.9) 
Mean Arterial Pressure, mmHg 98.0 (11.1) 98.1 (11.0) 
Low Density Lipoprotein Cholesterol, mg/dL 108.6 (36.5) 109.5 (36.8) 
High Density Lipoprotein Cholesterol, mg/dL 59.4 (18.3) 59.5 (18.1) 
HbA1c, mmol/mol 6.4 (1.2) 6.4 (1.2) 
Diabetes, % 29.6  29.4 
Body Mass Index, kg/m
2
 32.1 (7.2) 32.0 (7.2) 
Antihypertensive Medication, % 70.4 71.0 
Lipid Lowering Medication, % 43.5 43.4 
Diabetes Medication, % 27.4 27.2 
Antidepressant Medication, % 11.3 11.8 
†Number of Daily Fruit and Vegetable Servings 
(range: 0-6) 
4.0 (2.6) 3.9 (2.3) 
†C-Reactive Protein, mg/L 13.0 (17.3) 12.7 (16.6) 
Number of SLEs (possible range: 0-11) 4.4 (2.9) 4.3 (2.9) 
HAM-D-17 (possible range: 0-52) 5.2 (5.4) 5.2 (5.5) 
‡CES-D-SF (possible range: 0-33) 4.7 (5.3) 4.7 (5.4) 
CIMT, mm .83 (.14) -  
CAC, % -  68.8 
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Table 2  
Zero Order Correlations between Stressful Life Events, Depressive Symptoms and 
Subclinical Atherosclerosis 
Note. Bolded coefficients are significant at p < .05 level. SLEs = stressful life events. 
HAM-D-17 = 17-item Hamilton Rating Scale for Depression. CES-D-SF = Center for 
Epidemiologic Studies Depression Scale – Short Form. CIMT = Carotid Intima-Media 
Thickness. CAC = Coronary Artery Calcification.  
Coefficients in the non-shaded area are based on the CIMT cohort (N = 274) and 
coefficients in the shaded area are based on the CAC cohort (N = 279). 
† Correlations with the CES-D-SF variable are based on reduced sensitivity analysis 
samples: non-shaded area CIMT cohort N = 253 and shaded area CAC cohort N = 257.   
Variable 1 2 3 4 5 
1. Number of SLEs - .34 .25 .. -.09 
2. HAM-D-17  .35 - .75 .. .04 
3. † CES-D-SF  .25 .75 - .. .07 
4. CIMT, mm -.05 .06 .04 - .15 
5. CAC, % .. .. .. .15 - 
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Table 3 
Results of Regression Models Testing Main Effects of Number of Stressful Life Events 
(SLEs) and Depressive Symptoms on Carotid Intima-Media Thickness (CIMT) Coronary 
Artery Calcification (CAC) 
 CIMT 
(N = 274) 
CAC 
(N = 279) 
 
Demographic
-adjusted 
models† 
 
B (SEB) 
Fully- 
adjusted 
models‡ 
 
B (SEB) 
Demographic
-adjusted 
models† 
 
B (SEB) 
Fully- 
adjusted 
models‡ 
 
B (SEB) 
Number of SLEs 
-.0011 
(.0031) 
 .0001  
(.0031) 
-.0578  
(.0478) 
-.0752 
(.0528) 
HAM-D-17  
 .0016  
(.0016) 
 .0016  
(.0017) 
 .0217  
(.0251) 
 .0082  
(.0280) 
CES-D-SF◊  
 .0008  
(.0017) 
 .0007  
(.0018) 
 .0354  
(.0283) 
 .0303  
(.0316) 
Note. B = unstandardized regression coefficient. SEB = standard error of B. HAM-D-17 = 
17-item Hamilton Rating Scale for Depression. CES-D-SF = Center for Epidemiologic 
Studies Depression Scale – Short Form. 
†Adjusted for demographic factors (age, sex, and education). 
‡Adjusted for demographic factors (age, sex, and education), cardiovascular risk factors 
(mean arterial pressure, low-density lipoprotein, high-density lipoprotein, log 
transformed HbA1c, body mass index, and diabetes), and medication use 
(antihypertensive, lipid-lowering, diabetes, and antidepressant medication use ). 
◊Models with CES-D-SF score utilized reduced sensitivity analysis samples: CIMT 
cohort N = 253 and CAC cohort N = 257.  
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Table 4 
Results of Regression Models Testing the Stressful Life Events (SLEs) by Depressive 
Symptoms Interactions for Carotid Intima-Media Thickness (CIMT) and Coronary Artery 
Calcification (CAC) 
 
 CIMT 
(N = 274) 
CAC 
(N = 279) 
 
Demographic
-adjusted 
models† 
 
B (SEB) 
Fully- 
adjusted 
models‡ 
 
B (SEB) 
Demographic
-adjusted 
models† 
 
B (SEB) 
Fully- 
adjusted 
models‡ 
 
B (SEB) 
SLEs by HAM-D-17 
Interaction 
 .0002  
(.0005) 
 .0001  
(.0005) 
-.0057 
(.0085) 
-.0036 
(.0090) 
SLEs by CES-D-SF 
Interaction◊ 
 .0002  
(.0006) 
 .0001  
(.0006) 
-.0099 
(.0105) 
-.0077 
(.0110) 
Note. B = unstandardized regression coefficient. SEB = standard error of B. HAM-D-17 = 
17-item Hamilton Rating Scale for Depression. CES-D-SF = Center for Epidemiologic 
Studies Depression Scale – Short Form. 
†Adjusted for demographic factors (age, sex, and education). 
‡Adjusted for demographic factors (age, sex, and education), cardiovascular risk factors 
(mean arterial pressure, low-density lipoprotein, high-density lipoprotein, log 
transformed HbA1c, body mass index, and diabetes), and medication use 
(antihypertensive, lipid-lowering, diabetes, and antidepressant medication use ). 
◊Models with CES-D-SF score utilized reduced sensitivity analysis samples: CIMT n = 
253 and CAC n = 257. 
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Figure 1. Conceptual model depicting potential relationships among stressful life events, 
depression, and cardiovascular disease. CIMT = carotid intima-media thickness. CAC = 
coronary artery calcification. CVD = cardiovascular disease.  
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Figure 2. Conceptual model depicting hypothesized relationships among the variables 
examined in the present study. CIMT = carotid intima-media thickness. CAC = coronary 
artery calcification. 
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APPENDIX 
 
 
 
Life Events Interview 
 
 
Instructions: Use this form to guide the life events interview and to take notes.  Use the Life 
Events Record (LER) form to record data based on this interview. 
 
Severity Rating Scale: 
1 = Somewhat stressful: unpleasant, difficult, but not too serious. 
 NOTE: Do not record discrete Level 1 events on the LER form, but do code chronic 
Level 1 events. 
2 = Very stressful: e.g., caused significant loss or harm; created a lot of pressure; was 
difficult to cope  with; provoked a strong negative emotional reaction such fear, anxiety, 
anger, or discouragement; etc. 
3 = Extremely stressful or traumatic: e.g., caused severe loss or harm; was a terrible, 
devastating, 
 catastrophic experience; produced an intense or overwhelming emotional reaction; etc. 
 
Chronicity: Code the duration of the stressor, not the duration of its emotional or other effects 
on the patient. 
C = Chronic: stressful event or situation that lasted more than a few weeks; lasted months or 
years. 
D = Discrete: stressful event that lasted no more than a few hours, days, or weeks. 
 
Period: 
A = Adulthood; a stressful event or situation that occurred when patient was at least 18 years 
old. 
C = Childhood; a stressful event or situation occurred before patient was 18 years old. 
R = Recent; a stressful event or situation that occurred within the past 6 months. 
 
Carving Up Multifaceted Events:  A single event or situation might fit multiple categories. For 
example, the initiating (triggering) event may represent one kind of stressors, and the aftermath 
may represent several different kinds of stressors. E.g., a car crash might be coded as a serious 
injury, the months of rehab that followed might be coded as a stressful medical treatment, and 
the job loss due to accident-related disability might be coded as a financial or work-related 
problem. Thus, it might take several different codes to describe a car crash and its aftermath. 
 
In such cases, count the entire, complex situation as a single stressful life event if at all possible.  
This means that you should try to code it on a single row of the LER form.  Code as many 
categories as applies to the event. Within each category, pick the most stressful item that applies.  
E.g., for the car crash example above, you would enter 1 in column A if the injury itself was the 
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most stressful aspect of the medical situation.  If, on the other hand, the rehab was more stressful 
than the crash, you would enter 5 (rather than 1) in column A.   Since the crash also resulted in 
job loss due to disability, you would enter 4 in column C.  If a friend was entered in the same 
crash, you might enter a 5 in column D for the same event.   
 
Some aspects of a complex event might be more stressful than others; pick the severity rating 
corresponding to the worst level of stress that applies to the event.  E.g., if the crash was 
“extremely traumatic” but losing the job because of accident-related disability was “very 
stressful”, the event would be coded as a level 3.  Similarly, some aspects of the event may 
happen quickly (e.g., the crash), whereas others may unfold over a longer period of time (e.g., 
the rehab or the unemployment that followed).  If any part of the event is long-lasting, choose C 
for the chronicity code.  If none of it took longer than a few weeks to resolve, choose D. 
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Instructions for the Patient 
 
 
This interview is about the stressful experiences you’ve had during your lifetime.  I’m 
going to ask you about a variety of different kinds of stressful events and situations. I’m 
going to start by asking you about any stressful experiences you might have had in the past 
6 months. Next, we’ll talk about ones you’ve had during any other time in your adult life.  
Finally, we’ll talk about any serious stressful or traumatic experiences you might have had 
when you were a child or a teenager. Please let me know if there are any stressful or 
traumatic events that you don’t want to talk about, please let me know.  
 
Have you had any very stressful experiences or problems in the past 6 months?  If the 
participant brings up a recent SLE, probe for details so that you can code it in terms of 
categories, severity, and chronicity. (The period will be Recent). Whether or not the participant 
brings up an event (or more than one event), briefly review categories A through G. Adapt your 
questions so they fit with what the participant has already told you.  
 
Example: Besides the problem you just told me about, have you had any other stressful 
experiences in the past month?  How about any stressful medical problems or injuries?  
Any stressful changes in your living situation?  How about in your work or finances?  etc. 
 
Let’s think about other times in your adult life, before the last 6 months.  You’re in your 
(e.g., 70’s) now. How about in your 50’s or 60’s – did you have any very stressful 
experiences back then?  Like a very stressful medical problem, financial problem, or 
family problem, for instance?   
 
How about earlier in your adult life – when you were in your 30’s or 40’s?  Or when you 
were a young adult, in your 20’s? 
 
Now let’s talk about when you were a teenager – what were the most stressful things that 
happened to you back then?   
 
How about when you were a child?   
 
Review the list and ask: Can you think of anything else?  Any serious losses, any really 
stressful or traumatic experiences, anything that was hard to handle or hard to cope with? 
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Notes 
 
# Description  
1  Categories: 
 
 
 
Severity: 1 2 3 
Chronicity: Chronic Discrete 
Period: Child Adult Recent 
2  Categories: 
 
 
 
Severity: 1 2 3 
Chronicity: Chronic Discrete 
Period: Child Adult Recent 
3  Categories: 
 
 
 
Severity: 1 2 3 
Chronicity: Chronic Discrete 
Period: Child Adult Recent 
4  Categories: 
 
 
 
Severity: 1 2 3 
Chronicity: Chronic Discrete 
Period: Child Adult Recent 
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Event Categories and Codes 
 
A. Medical Illnesses, Injuries, Medical 
Care 
A1.Serious illness or injury 
A2. Hospitalized for serious illness 
A3. Hospitalized for serious injury 
A4. Major surgery 
A5. Stressful medical treatment 
A6. Other stressful medical event or situation 
A7. Multiple events in this category 
B. Stressful Changes in Living 
Arrangement 
B1. Relocation to nursing home | other care 
facility 
B2. Lost home to fire, flood, or other disaster 
B3. Lost home for financial or other reasons 
B4. Became homeless 
B5. Incarcerated in jail, prison, or other 
institution 
B6. Other stressful change in living 
arrangement 
B7. Multiple events in this category 
C. Financial, Work, or School-Related 
Problems 
C1. Serious financial crisis 
C2. Laid off of job 
C3. Fired from job 
C4. Lost job due to disability 
C5. Lost job for other reason 
C6. Had to change job or career 
C7. Had to quit school 
C8. Failed out of school 
C9. Other stressful financial, work, or school 
problem 
C10. Multiple events in this category 
D. Non-Family Relationship 
Problems 
D1. Break-up of romantic relationship 
D2. Serious illness of boyfriend | girlfriend | 
partner 
D3. Death of boyfriend | girlfriend | partner 
D4. Estrangement | separation from friend | 
confidant 
D5. Serious injury or illness of friend | 
confidant 
D6. Death of close friend | confidant 
D7. Social isolation or rejection 
D8. Other relationship crisis | loss 
D9. Multiple events in this category 
E. Marital Relationships 
E1. Separation, divorce, or break-up 
E2. Serious injury or illness of current spouse 
E3. Death of current spouse 
E4. Serious injury or illness of former spouse 
E5. Death of former spouse 
E6. Serious injury or illness of my child’s other 
parent 
E7. Death of my child’s other parent 
E8. Other marital crisis or loss 
E9. Multiple events in this category 
F. Family Relationships 
F1. Birth or adoption of a child 
F2. Stillbirth, miscarriage, or abortion 
F3. Serious injury or illness of a minor child 
F4. Death of a minor child 
F5. Serious injury or illness of an adult child 
F6. Death of an adult child 
F7. Serious injury or illness of parent 
F8. Death of parent 
F9. Serious injury or illness of other family 
member 
F10. Death of other family member 
F11. Family member victim of crime 
F12. Family member victim of disaster 
F13. Other family crisis or loss 
F14. Multiple events in this category 
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G. Violence or Trauma 
G1. Victim of serious nonviolent crime 
G2. Victim of violent crime 
G3. Victim of sexual assault 
G4. Victim of sexual abuse 
G5. Victim of physical abuse 
G6. Victim of emotional abuse 
G7. Victim of neglect or abandonment 
G8. Victim of natural disaster 
G9. Victim of man-made accident or disaster 
G10. Victim of terrorism, riot, or other violent 
event 
G11. Witnessed violent crime or traumatic 
event 
G12. Military deployment to a war or disaster 
zone 
G13. Participation in military combat 
G14. Other violent or traumatic event in 
adulthood 
G15. Multiple events in this category 
H. Childhood 
H1. Parents separated or divorced 
H2. Moved to foster home or care facility 
H3. Moved to other place away from home 
H4. Other childhood problem 
H5. Multiple events in this category 
 
 
